as on January 12, 2026 at 4:01 pm IST
Day's Low
Day's High
2.07%
Downside
4.62%
Upside
52 Week's Low
52 Week's High
40.70%
Downside
4.62%
Upside
as on January 12, 2026 at 4:01 pm IST
Market Cap
₹29,205.55 Cr
Return on Equity (ROE)
12.79
PE Ratio (TTM)
36.8
Return on capital employed (ROCE)
14.36
Industry PE ratio
42.25
Beta (LTM)
1.22
P/B Ratio
6.72
Dividend Yield
0.28
PEG Ratio
3.33
Quarterly Earnings Growth YOY
24.72
EPS (TTM)
37.34
Sector
Pharmaceuticals
Book Value
234.65
Technical Analysis
Bullish
View Technical Analysis
as on January 12, 2026 at 4:01 pm IST
Emcure Pharma in the last 5 years
Lowest (24.97x)
April 9, 2025
Today (36.80x)
January 9, 2026
Industry (42.25x)
January 9, 2026
Highest (53.98x)
September 18, 2024
Today’s Price to Earnings Ratio: 36.80x
Compare market cap, revenue, PE, and other key metrics of Emcure Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 29,205.55 | 2.67% | 0.63 | 707 | 7,896 | |
| NA | 104.86 | -1.6% | 0.00 | 6 | 49 | |
| NA | 23.32 | -11.33% | 0.82 | 3 | 168 | |
| NA | 1,196.74 | 357.22% | 0.65 | 39 | 370 | |
| NA | 375.98 | 92.14% | 0.95 | -14 | 125 |
Based on 6 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 6 analysts, 83.33% of analysts recommend a 'BUY' rating for Emcure Pharma . Average target price of ₹1681.83
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on Emcure Pharma .
What analysts predicted
9.17%UPSIDE
Target Price
₹1681.83
Current Price
₹1499.1
Analyzed by
6 Analysts
High
₹1750
Target
₹1681.83
Low
₹1550
Emcure Pharma target price ₹1681.83, a slight upside of 9.17% compared to current price of ₹1499.1. According to 6 analysts rating.
Source: S&P Global Market Intelligence
Search interest for Emcure Pharmaceuticals Ltd Stock has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Emcure Pharma .
Emcure Pharmaceuticals Ltd’s net profit jumped 25.13% since last year same period to ₹243.46Cr in the Q2 2025-2026. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated 17.64% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Emcure Pharmaceuticals Ltd has declared dividend of ₹3.00 per share on 22 May 2025 - translating a dividend yield of 0.19%.
Read More about DividendsCheck stock indices that include Emcure Pharma .
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
![]()
Mutual Funds have increased holdings from 2.34% to 3.58% in Sep 2025 quarter
Price Rise
![]()
In the last 7 days, EMCURE stock has moved up by 3.4%
FII Holding Up
![]()
Foreign Institutions have increased holdings from 2.86% to 3.29% in Sep 2025 quarter
Promoter Holding Down
![]()
Promoters have decreased holdings from 77.91% to 77.88% in Sep 2025 quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 16.39% to 14.46% in Sep 2025 quarter
| Organisation | Emcure Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Emcure Pharma share price today stands at ₹1499.1 as on at the close of the market. Emcure Pharma share today touched a day high of ₹1568.3 and a low of ₹1468.1.
Emcure Pharma touched a 52 week high of ₹1568.3 and a 52 week low of ₹889. Emcure Pharma share price today i.e. is closed at ₹1499.1, which is -4.41% down from its 52 week high and 68.63% up from its 52 week low.
Emcure Pharma market capitalisation is ₹29,205.55 Cr as on .
To buy Emcure Pharma shares, you need to follow these steps:
Emcure Pharma trading volume is 3.35L as on . This means that 3.35L shares of Emcure Pharma were bought and sold on the stock market during today's trading session.